Insider Trading February 17, 2026

AeroVironment Director Sells $127,475 in Stock Amid Ongoing Growth and Contract Wins

Stephen F. Page executed a planned sale under a 10b5-1 trust arrangement while the company posts strong share gains and secures major defense work

By Avery Klein AVAV
AeroVironment Director Sells $127,475 in Stock Amid Ongoing Growth and Contract Wins
AVAV

Stephen F. Page, a director at AeroVironment Inc (AVAV), sold 500 shares on February 17, 2026, under a pre-established Rule 10b5-1 plan for $127,475. The company continues to see significant market appreciation and recent contract awards despite trailing twelve-month losses and mixed insider positioning.

Key Points

  • Director Stephen F. Page sold 500 shares on February 17, 2026, at $254.95 for $127,475.
  • Page holds 1,705 shares directly and 50,501 shares indirectly via the Stephen F. Page Living Trust; the sale used a Rule 10b5-1 plan adopted September 30, 2025, with Colby Petersen signing the Form 4.
  • AeroVironment has a $13.12 billion market cap, produced a 67.52% return over the past year, received positive analyst ratings, and secured a $75 million, five-year U.S. Air Force task order under the FRESH program.

Stephen F. Page, a member of the board of AeroVironment Inc (NASDAQ: AVAV), reported the sale of 500 shares of the company’s common stock on February 17, 2026. The block of shares was disposed of at $254.95 per share, yielding a total transaction value of $127,475.

At the time of reporting the stock is trading at $263.02, modestly above the price at which Page executed the sale. Independent analysis referenced in company reporting indicates the shares were trading above their Fair Value at the time of the transaction.

Following the disposition, Page retains direct ownership of 1,705 shares and maintains indirect holdings of 50,501 shares held through the Stephen F. Page Living Trust.

The sale was carried out under a Rule 10b5-1 trading plan that the Stephen F. Page Living Trust adopted on September 30, 2025. Colby Petersen, acting as attorney-in-fact, signed the Form 4 reporting the transaction on Page’s behalf.


Financial and market context for the company remains notable. AeroVironment is carrying a market capitalization of $13.12 billion and has delivered a 67.52% total return over the last 12 months. Those gains have occurred despite the company not reporting profitability over the trailing twelve-month period.

Analyst coverage is currently favorable, with a consensus leaning toward strong buy and with the next earnings release expected in 21 days. Sell-side price targets cited by market commentators include an Overweight rating from JPMorgan with a $320.00 target and a Market Outperform rating from another firm with a $400.00 target, both of which highlight the company’s exposure to fast-growing defense-related segments such as drones and space.

On the business development front, AeroVironment announced a five-year, $75 million task order awarded by the U.S. Air Force to its UES division. The work is part of the Functional Responsive Experimentation for Systems and Humans - FRESH - program and focuses on developing advanced biotechnology and smart materials aimed at enhancing Air Force capabilities.

The company is identified as a significant participant in the global drone market, which industry projections place at roughly $53.45 billion by 2026. These contract awards and favorable analyst coverage underline the strategic positioning that market observers point to when assessing AeroVironment’s growth outlook.


Key points:

  • Director Stephen F. Page sold 500 shares on February 17, 2026, at $254.95 each, totaling $127,475.
  • Page now holds 1,705 shares directly and 50,501 indirectly through his living trust; the sale was executed under a Rule 10b5-1 plan adopted September 30, 2025, with Colby Petersen signing the Form 4.
  • AeroVironment has a $13.12 billion market capitalization, a 67.52% return over the past year, active analyst bullishness, and a recent $75 million, five-year U.S. Air Force task order under the FRESH program.

Risks and uncertainties:

  • The company reported no profitability in the trailing twelve months despite strong share-price appreciation, presenting earnings and margin execution risk for equity holders.
  • Analyst expectations and price targets reflect optimism; forthcoming quarterly results in 21 days could alter consensus views and market sentiment.
  • Large defense contracts and exposure to the drone market tie AeroVironment’s near-term outlook to government procurement cycles and defense spending priorities.

Risks

  • The company has not been profitable over the trailing twelve months despite strong share-price appreciation, creating earnings risk for investors.
  • Upcoming earnings expected in 21 days may change analyst sentiment and affect the stock’s trajectory.
  • Reliance on defense contracts and the drone market exposes the company to procurement cycle and defense-spending variability.

More from Insider Trading

Culp Inc CCO Acquires 10,000 Shares as Company Grapples with Weak Quarterly Results Apr 6, 2026 Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026